XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 44,755 $ 187,026
Investments in marketable securities 235,087 143,325
Accounts receivable 1,875 1,304
Inventories 3,698 3,416
Prepaid expenses and other current assets 10,792 4,993
Total current assets 296,207 340,064
Property and equipment, less accumulated depreciation of $13,316 and $12,495 at March 31, 2017 and December 31, 2016, respectively 9,745 9,816
In-process research & development 486,700 486,700
Goodwill 197,797 197,797
Other non-current assets 2,932 2,468
Total Assets 993,381 1,036,845
Current liabilities:    
Accounts payable, accrued expenses , and other current liabilities 39,645 41,008
Deferred reimbursements, current portion 13,850 13,850
Contingent consideration payable, current portion 56,101 56,101
Total current liabilities 109,596 110,959
Deferred reimbursements 21,906 21,906
Convertible notes 156,859 154,464
Contingent consideration payable 218,199 213,621
Deferred income taxes 173,820 173,771
Other non-current liability 2,223 1,973
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value, 250,000,000 shares authorized, 142,829,530 and 142,691,986 shares issued and outstanding at March 31, 2017, and December 31, 2016, respectively 1,482 1,480
Additional paid-in capital 1,126,148 1,120,156
Accumulated other comprehensive loss:    
Foreign currency translation adjustment, less tax expense of $1,293 at March 31, 2017 and December 31, 2016 1,487 1,945
Unrealized gain on available-for securities 185 102
Warrants 16,076 16,076
Accumulated deficit (834,600) (779,608)
Total stockholders' equity 310,778 360,151
Total Liabilities and Stockholders' Equity $ 993,381 $ 1,036,845